Treatment of hemolysis with intravenous unfractionated heparin using an antifactor Xa-based monitoring protocol

J Thorac Cardiovasc Surg. 2015 May;149(5):1465-6. doi: 10.1016/j.jtcvs.2015.02.029.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous
  • Aged
  • Biomarkers / blood
  • Drug Monitoring / methods*
  • Factor Xa / metabolism*
  • Factor Xa Inhibitors / administration & dosage*
  • Factor Xa Inhibitors / adverse effects
  • Heart Failure / blood
  • Heart Failure / diagnosis
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart-Assist Devices / adverse effects*
  • Hemolysis / drug effects*
  • Heparin / administration & dosage*
  • Heparin / adverse effects
  • Humans
  • Male
  • Partial Thromboplastin Time
  • Predictive Value of Tests
  • Prosthesis Design
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left

Substances

  • Biomarkers
  • Factor Xa Inhibitors
  • Heparin
  • Factor Xa